ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

524
Analysis
Health Care • South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bullish•SK Hynix
•03 Jul 2026 14:23

Korean Holdcos Vs Opcos Gap Trading Opportunities in 3Q 2026

In this insight, I highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in...

Logo
204 Views
Share
•07 Jan 2021 04:39

Can You Profit from the KR Retail Investor? (Btw You Already Probably Have Met Him)

I wanted to share my thoughts as I follow the retail moves and share not only who the powerful or mover/shaker Korean retail investor as they now...

Logo
627 Views
Share
•01 Jul 2026 14:25

MS-South Korea Index Earning Revision (Jun): Samsung Electronics, HANKOOK TIRE & TECHNOLOGY, KAL

We analyzed MS-South Korea's consensus for Jun 2026 and highlighted changes of EPS in Samsung Electronics, HANKOOK TIRE & TECHNOLOGY, DB INSURANCE,...

Logo
100 Views
Share
•30 Jun 2026 19:40

KRX Short Interest Weekly (Jun 26th): HyundaiAutoever, JEL, Hyundai Motor, MIRAE ASSET SEC

We analyzed KRX short interest report for the past week and highlighted short interest changes in HyundaiAutoever, JEL, Hyundai Motor, MIRAE ASSET...

Logo
136 Views
Share
•09 Sep 2020 12:18

The Stocks to Own in Asia – Vol. 30

We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology. Our research team constantly reviews the Asia markets...

Share
x